Differences

This shows you the differences between two versions of the page.

--- resources:research:leads [2025/02/18 19:55] – [MDA5] admin
+++ resources:research:leads [2026/03/11 08:31] (current) – [Outside Institutions] admin
@@ Line 1: / Line 1: @@
+===== Outside Institutions =====
+  * [[https://reporter.nih.gov/search/8Zd8KlnZjkOzJZo5POhsSg/project-details/11193816 | PENN: JOHNSON, CHEILONDA]]
+  * [[https://reporter.nih.gov/search/Udp83l3pmEuCJZmReu84kw/project-details/11112549 | VANDERBILT: WILFONG, ERIN M]]
+  * [[ | UCLA: BAE, SANGMEE]]
+  * [[https://reporter.nih.gov/search/-rJ6-9OHKki8b6uLuaZ5nQ/project-details/11199890#description | UCLA: VOLKMAN, ELIZABETH]]
+===== Myositis Clinical Trials Consortium =====
+  * [[https://myositisclinicaltrialsconsortium.org]]
+===== Secondary Data Analysis ====
+  * [[https://datatools.ahrq.gov/]]
 ===== MDA5 =====
-  * Kyoto University group, famous for [[https://doi.org/10.1002/art.41105 | pred + tacro + CYC for RP-ILD a/w MDA5]]
+  * **Kyoto University group**
+    * famous for [[https://doi.org/10.1002/art.41105 | pred + tacro + CYC for RP-ILD a/w MDA5]]
     * important names:
       * Ran Nakashima
-  * Chiba University
+      * Tsuneyo Mimori
+  * **Chiba University**
     * [[https://doi.org/10.1136/rmdopen-2022-002795 | Tofacitinib for refractory MDA5]]
 ====== FAPi Scans ======

ewrobbins.com